Back to Search Start Over

Diagnostic techniques for COVID-19: A mini-review.

Authors :
Wu, Xianyong
Chen, Qiming
Li, Junhai
Liu, Zhanmin
Source :
Journal of Virological Methods. Mar2022, Vol. 301, pN.PAG-N.PAG. 1p.
Publication Year :
2022

Abstract

• This review mainly reviewed the diagnostic techniques of COVID-19. • Sampling and sample treatment greatly affect nucleic acid testing (NAT) results. • Novel NAT assays such as CRISPR/Cas-based assays have been developed. • NAT, immunological methods, and CT imaging have different roles in COVID-19 diagnostics. • A combination of NAT, immunological methods, and CT imaging improves diagnostic accuracy. COVID-19, a new respiratory infectious disease, was first reported at the end of 2019, in Wuhan, China. Now, COVID-19 is still causing major loss of human life and economic productivity in almost all countries around the world. Early detection, early isolation, and early diagnosis of COVID-19 patients and asymptomatic carriers are essential to blocking the spread of the pandemic. This paper briefly reviewed COVID-19 diagnostic assays for clinical application, including nucleic acid tests, immunological methods, and Computed Tomography (CT) imaging. Nucleic acid tests (NAT) target the virus genome and indicates the existence of the SARS-CoV-2 virus. Currently, real-time quantitative PCR (qPCR) is the most widely used NAT and, basically, is the most used diagnostic assay for COVID-19. Besides qPCR, many novel rapid and sensitive NAT assays were also developed. Serological testing (detection of serum antibodies specific to SARS-CoV-2), which belongs to the immunological methods, is also used in the diagnosis of COVID-19. The positive results of serological testing indicate the presence of antibodies specific to SARS-CoV-2 resulting from being infected with the virus. Viral antigen detection assays are also important immunological methods used mainly for rapid virus detection. However, only a few of these assays had been reported. CT imaging is still an important auxiliary diagnosis tool for COVID-19 patients, especially for symptomatic patients in the early stage, whose viral load is low and different to be identified by NAT. These diagnostic techniques are all good in some way and applying a combination of them will greatly improve the accuracy of COVID-19 diagnostics. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
01660934
Volume :
301
Database :
Academic Search Index
Journal :
Journal of Virological Methods
Publication Type :
Academic Journal
Accession number :
155258142
Full Text :
https://doi.org/10.1016/j.jviromet.2021.114437